AR066649A1 - Reovirus mutantes y metodos de elaboracion y uso de los mismos - Google Patents
Reovirus mutantes y metodos de elaboracion y uso de los mismosInfo
- Publication number
- AR066649A1 AR066649A1 ARP080102139A ARP080102139A AR066649A1 AR 066649 A1 AR066649 A1 AR 066649A1 AR P080102139 A ARP080102139 A AR P080102139A AR P080102139 A ARP080102139 A AR P080102139A AR 066649 A1 AR066649 A1 AR 066649A1
- Authority
- AR
- Argentina
- Prior art keywords
- reovirus
- methods
- elaboration
- mutants
- same
- Prior art date
Links
- 241000702263 Reovirus sp. Species 0.000 title abstract 6
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 230000035772 mutation Effects 0.000 abstract 2
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000002458 infectious effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/13—Tumour cells, irrespective of tissue of origin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US93925507P | 2007-05-21 | 2007-05-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR066649A1 true AR066649A1 (es) | 2009-09-02 |
Family
ID=40031362
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP080102139A AR066649A1 (es) | 2007-05-21 | 2008-05-20 | Reovirus mutantes y metodos de elaboracion y uso de los mismos |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20080292594A1 (https=) |
| EP (1) | EP2150613B1 (https=) |
| JP (1) | JP2010527593A (https=) |
| CN (2) | CN104195115A (https=) |
| AR (1) | AR066649A1 (https=) |
| AU (1) | AU2008253505B2 (https=) |
| CA (1) | CA2680661C (https=) |
| DK (1) | DK2150613T3 (https=) |
| ES (1) | ES2611455T3 (https=) |
| IL (1) | IL200690A (https=) |
| MX (1) | MX2009012420A (https=) |
| TW (1) | TW200909581A (https=) |
| WO (1) | WO2008141448A1 (https=) |
| ZA (1) | ZA200907017B (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0720624D0 (en) * | 2007-10-20 | 2007-11-28 | Academisch Ziekenhuis Leiden | Viral Modification |
| JP2011500608A (ja) * | 2007-10-22 | 2011-01-06 | オンコリティクス バイオテク，インコーポレーテッド | 増殖性障害の治療レジメン |
| EP2296678A4 (en) * | 2008-05-27 | 2012-03-21 | Oncolytics Biotech Inc | MODULATION OF INTERSTITIAL PRESSURE AND ONCOLYTIC VIRUS RELIEF AND DISTRIBUTION |
| WO2009143611A1 (en) * | 2008-05-27 | 2009-12-03 | Oncolytics Biotech Inc. | Abrogating proinflammatory cytokine production during oncolytic reovirus therapy |
| EP2646051A4 (en) | 2010-12-02 | 2014-05-28 | Oncolytics Biotech Inc | FORMULATIONS OF LIQUID VIRUSES |
| MX349294B (es) | 2010-12-02 | 2017-07-21 | Oncolytics Biotech Inc | Formulaciones virales liofilizadas. |
| DK3068411T3 (da) | 2013-11-15 | 2020-06-22 | Oncolytics Biotech Inc | Oncolytiske vira og forøget cancerbehandlingsregimer |
| EP3417866B1 (en) | 2016-02-16 | 2020-12-23 | Osaka University | Medicinal composition for treating fibrosis |
| KR20210098202A (ko) * | 2020-01-31 | 2021-08-10 | 바이로큐어 주식회사 | 레오바이러스를 유효성분으로 포함하는 대장염의 예방 또는 치료용 조성물 |
| CN116917468A (zh) * | 2020-12-22 | 2023-10-20 | 百洛克株式会社 | 新型修饰的呼肠孤病毒及其用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4554101A (en) * | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
| US5023252A (en) * | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
| US6110461A (en) * | 1997-08-13 | 2000-08-29 | Oncolytics Biotech Inc. | Reovirus for the treatment of neoplasia |
| US6136307A (en) * | 1997-08-13 | 2000-10-24 | Oncolytics Biotech Inc. | Reovirus for the treatment of cellular proliferative disorders |
| US6565831B1 (en) * | 1999-02-24 | 2003-05-20 | Oncolytics Biotech Inc. | Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
| DE69937999T2 (de) * | 1998-06-12 | 2009-01-29 | Avir Green Hills Biotechnology Research Development Trade Ag | Interferon induzierende genetisch veränderte attenuierte viren |
| TWI289158B (en) * | 2000-08-10 | 2007-11-01 | Oncolytics Biotech Inc | Method of producing infectious reovirus |
| NZ524937A (en) * | 2000-11-09 | 2004-10-29 | Oncolytics Biotech Inc | Methods for determining susceptibility of a cell to reovirus infection and for diagnosing proliferative disease treatable with reovirus |
| IL157304A0 (en) * | 2001-03-16 | 2004-02-19 | Oncolytics Biotech Inc | Method of extracting virus from cell culture |
| US7163678B2 (en) * | 2002-11-07 | 2007-01-16 | Oncolytics Biotech Inc. | Reovirus for the treatment of ral-mediated cellular proliferative disorders |
| WO2005111200A1 (en) * | 2004-05-17 | 2005-11-24 | Universite De Montreal | Novel strains of reoviruses and methods of uses thereof |
| US10260049B2 (en) * | 2005-08-01 | 2019-04-16 | Virocure, Inc. | Attenuated reovirus |
-
2008
- 2008-05-20 TW TW097118468A patent/TW200909581A/zh unknown
- 2008-05-20 AR ARP080102139A patent/AR066649A1/es unknown
- 2008-05-21 ES ES08748334.3T patent/ES2611455T3/es active Active
- 2008-05-21 CN CN201410339446.7A patent/CN104195115A/zh active Pending
- 2008-05-21 CA CA2680661A patent/CA2680661C/en active Active
- 2008-05-21 JP JP2010508676A patent/JP2010527593A/ja active Pending
- 2008-05-21 DK DK08748334.3T patent/DK2150613T3/en active
- 2008-05-21 MX MX2009012420A patent/MX2009012420A/es active IP Right Grant
- 2008-05-21 CN CN200880016669A patent/CN101679953A/zh active Pending
- 2008-05-21 US US12/124,522 patent/US20080292594A1/en not_active Abandoned
- 2008-05-21 WO PCT/CA2008/000964 patent/WO2008141448A1/en not_active Ceased
- 2008-05-21 EP EP08748334.3A patent/EP2150613B1/en active Active
- 2008-05-21 AU AU2008253505A patent/AU2008253505B2/en active Active
-
2009
- 2009-09-02 IL IL200690A patent/IL200690A/en active IP Right Grant
- 2009-10-08 ZA ZA2009/07017A patent/ZA200907017B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW200909581A (en) | 2009-03-01 |
| EP2150613A4 (en) | 2011-01-19 |
| HK1136006A1 (en) | 2010-06-18 |
| MX2009012420A (es) | 2009-12-09 |
| IL200690A (en) | 2014-02-27 |
| CN101679953A (zh) | 2010-03-24 |
| AU2008253505B2 (en) | 2014-09-04 |
| EP2150613A1 (en) | 2010-02-10 |
| WO2008141448A1 (en) | 2008-11-27 |
| EP2150613B1 (en) | 2016-10-19 |
| US20080292594A1 (en) | 2008-11-27 |
| CN104195115A (zh) | 2014-12-10 |
| ZA200907017B (en) | 2010-12-29 |
| AU2008253505A1 (en) | 2008-11-27 |
| IL200690A0 (en) | 2011-08-01 |
| CA2680661C (en) | 2018-05-29 |
| ES2611455T3 (es) | 2017-05-09 |
| JP2010527593A (ja) | 2010-08-19 |
| CA2680661A1 (en) | 2008-11-27 |
| DK2150613T3 (en) | 2017-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR066649A1 (es) | Reovirus mutantes y metodos de elaboracion y uso de los mismos | |
| ES2524458T3 (es) | DNasa para el tratamiento de la subfertilidad masculina | |
| ATE553792T1 (de) | Medizinische vorrichtungen mit verbundstoffen | |
| EP1276486B8 (en) | Joint repair using mesenchymal stem cells | |
| AR064725A1 (es) | Profilaxis y tratamiento del complejo respiratorio porcino (prdc). uso | |
| AR055052A1 (es) | Metodos para tratamiento de trastornos inmunes asociados con transplante de injerto con moleculas mutantes del antigeno 4 del linfocito t citotoxico (ctla4) solubles | |
| WO2008118392A3 (en) | Synthetic cell platforms and methods of use thereof | |
| AU2008326599A8 (en) | Modulation of the immune response | |
| PL1635863T3 (pl) | Kompozycje do wywoływania, wzmacniania i utrzymywania odpowiedzi immunologicznych na epitopy ograniczone do MHC klasy I do celów profilaktycznych i leczniczych | |
| ECSP088831A (es) | Anticuerpos anti-tat226 e inmunoconjugados | |
| TW200712688A (en) | Light diffusing films, methods of making the same, and articles using the same | |
| MX2009013706A (es) | Celulas multipotentes/pluripotentes y metodos relacionados. | |
| NO20083147L (no) | Anti-OX40L-antistoffer og fremgangsmater for anvendelse av disse | |
| GT200800065A (es) | Métodos y composiciones para modular la hemostasia | |
| MX2025003742A (es) | Anticuerpos anti-cd122 y usos de los mismos | |
| ES2571979T3 (es) | Procedimiento para aumentar la presentación de clase I de antígenos exógenos por células dendríticas humanas | |
| AR054937A1 (es) | Goma de mascar biodegradable | |
| SG158154A1 (en) | Methods to elicit, enhance and sustain immune responses against mhc class i-restricted epitopes, for prophylactic or therapeutic purposes | |
| WO2006047743A3 (en) | Swine multipotent adult progenitor cells | |
| AU308253S (en) | High chair | |
| AR048534A1 (es) | Formulaciones de acetato de bazedoxifeno | |
| DK1272127T3 (da) | Fremgangsmådet til fremstilling af ligament-erstatningskonstruktioner | |
| WO2023159136A3 (en) | Epitope engineering of cell-surface receptors | |
| WO2008120201A3 (en) | An isolated population of cells and methods of generating and using same | |
| DE60327710D1 (de) | Modifizierte zytokine für krebs therapie |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |